• ICH GCP
    • Dansk
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Magyar
    • Nederlands
    • Norsk
    • Polski
    • Português
    • Suomi
    • Svenska
    • Čeština
    • Русский
    • 日本語
    • 简体中文
    • 한국어
  • Regulations
    • USA (FDA)
    • UK (MHRA)
    • AUSTRALIA (NHMRC)
    • JAPAN (PMDA)
  • CRO List
  • Clinical Trials
    • US Clinical Trials Registry
    • EU Clinical Trials Registry
    • Pharmaceutical Companies
    • Clinical Research Labs
    • Clinical Research Events
    • Publications
    • Researchers
  • Jobs
  • Publications
  • News
  • Regulations
    • GLOBAL (ICH GCP)
    • USA (FDA)
    • UK (MHRA)
    • AUSTRALIA (NHMRC)
    • JAPAN (PMDA)
    • EU (EMA)
  • CRO List
  • Clinical Trials
    • US Clinical Trials Registry
    • EU Clinical Trials Registry
    • Pharmaceutical Companies
    • Clinical Research Labs
    • Service Companies
    • Clinical Research Events
    • Publications
    • Researchers
  • Jobs
  • Publications
  • News
Example: Heart Attack
  • Glossary
  • Understanding Clinical Trials

Search clinical trials for: ESSDAI

Total 12 results


  • NCT05217472
    Withdrawn
    An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)
    Sjogren's Syndrome (SS)
  • NCT07737743
    Recruiting
    A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
    Sjögren's Disease
  • NCT07621809
    Recruiting
    Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden (THALASSA)
    Sjögren´s Disease
  • NCT06104124
    Completed
    A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
    Sjogren's Syndrome
  • NCT03905525
    Completed
    Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome (TWINSS)
    Sjögren Syndrome

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.

«Manage Settings
Regulations
  • GLOBAL (ICH GCP)
  • USA (FDA)
  • UK (MHRA)
  • AUSTRALIA (NHMRC)
  • JAPAN (PMDA)
  • EU (EMA)
Resources
  • CRO List
  • Pharmaceutical Companies
  • Clinical Research Labs
  • Service Companies
  • Jobs
  • US Clinical Trials Registry
  • EU Clinical Trials Registry
Articles
  • Publications
  • News
  • About us / Our mission
Language
Dansk Deutsch English Español Français Italiano Magyar Nederlands Norsk Polski Português Suomi Svenska Čeština Русский 日本語 简体中文 한국어
  • Sitemap
  • Contact us
  • RSS feed
  • Privacy Policy
  • Disclaimer
© ICH GCP. All Rights Reserved.